ARCHIVES

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

This article is from The Cancer Letter archive.

Vol. 03 No. 36 | September 9, 1977

Download PDF Visit The Full Archive

Related Articles

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

Immunoassays For Isoenzymes

April 15, 1983

New Treatment Approaches Valuable For Cancer Pain, Quality Of Life

September 27, 2002

AACI To Become More Aggressive In Developing National Issues; Planning To Start on Collaborate Diagnosis Network

July 15, 1983

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993